Literature DB >> 8540843

Metastatic ocular and cutaneous melanoma: a comparison of patient characteristics and prognosis.

D M Albert, L M Ryan, E C Borden.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8540843

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  14 in total

1.  A pilot study of bevacizumab and interferon-α2b in ocular melanoma.

Authors:  Kristan D Guenterberg; Valerie P Grignol; Kiran V Relekar; Kimberly A Varker; Helen X Chen; Kari L Kendra; Thomas E Olencki; William E Carson
Journal:  Am J Clin Oncol       Date:  2011-02       Impact factor: 2.339

2.  Two cases of partial hepatectomy for malignant melanoma.

Authors:  Aaron I Karlen; Justin J Clark; Linda L Wong
Journal:  Hawaii J Med Public Health       Date:  2012-04

3.  Comparing vasculogenic mimicry with endothelial cell-lined vessels: techniques for 3D reconstruction and quantitative analysis of tissue components from archival paraffin blocks.

Authors:  Amy Y Lin; Zhuming Ai; Sang-Chul Lee; Peter Bajcsy; Jacob Pe'er; Lu Leach; Andrew J Maniotis; Robert Folberg
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-03

4.  Laparoscopic liver resection for metastatic melanoma.

Authors:  Davit L Aghayan; Airazat M Kazaryan; Åsmund Avdem Fretland; Mushegh A Sahakyan; Bård I Røsok; Bjørn Atle Bjørnbeth; Bjørn Edwin
Journal:  Surg Endosc       Date:  2017-09-15       Impact factor: 4.584

5.  Whole body PET/CT for initial staging of choroidal melanoma.

Authors:  P T Finger; M Kurli; S Reddy; L B Tena; A C Pavlick
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

6.  Limited value of 18F-FDG PET/CT and S-100B tumour marker in the detection of liver metastases from uveal melanoma compared to liver metastases from cutaneous melanoma.

Authors:  K Strobel; B Bode; R Dummer; P Veit-Haibach; D R Fischer; L Imhof; S Goldinger; Hans C Steinert; G K von Schulthess
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-04       Impact factor: 9.236

7.  Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience.

Authors:  Jason J Luke; Margaret K Callahan; Michael A Postow; Emanuela Romano; Nikhil Ramaiya; Mark Bluth; Anita Giobbie-Hurder; Donald P Lawrence; Nageatte Ibrahim; Patrick A Ott; Keith T Flaherty; Ryan J Sullivan; James J Harding; Sandra D'Angelo; Mark Dickson; Gary K Schwartz; Paul B Chapman; Jedd D Wolchok; F Stephen Hodi; Richard D Carvajal
Journal:  Cancer       Date:  2013-08-02       Impact factor: 6.860

8.  Multinodular goiter and primary hyperparathyroidism: a circuitous route to diagnosing metastatic uveal melanoma.

Authors:  Constantine G A Theoharis; Tobias Carling; Natalia Buza; Eduardo Zambrano; Julie Ann Sosa
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 9.  Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.

Authors:  Romany A N Johnpulle; Douglas B Johnson; Jeffrey A Sosman
Journal:  Curr Oncol Rep       Date:  2016-01       Impact factor: 5.945

10.  Beta1-6 branching of cell surface glycoproteins may contribute to uveal melanoma progression by up-regulating cell motility.

Authors:  Małgorzata Przybyło; Ewa Pocheć; Paweł Link-Lenczowski; Anna Lityńska
Journal:  Mol Vis       Date:  2008-03-26       Impact factor: 2.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.